Specific cd4+cd25+ regulatory t cells for haematopoietic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/14 (2006.01) A61K 35/30 (2006.01) A61P 37/06 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2643580

The invention relates to a pharmaceutical composition comprising CD4+ CD25+ regulatory T cells specific for at least one minor histocompatibility antigen, and also to stem cells, advantageously haematopoietic stem cells, carrying at least said antigen. Such a composition can be used as a medicament for increasing the immune tolerance of a histocompatible host.

L'invention concerne une composition pharmaceutique comprenant des cellules T in régulatrices CD4+ CD25+ spécifiques d'au moins un antigène mineur au d'histocompatibilité, ainsi que des cellules souches avantageusement hématopoïétiques porteuses d'au moins ledit antigène. Une telle composition peut être utilisée comme médicament pour augmenter la tolérance immunitaire d'un hôte histocompatible.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Specific cd4+cd25+ regulatory t cells for haematopoietic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific cd4+cd25+ regulatory t cells for haematopoietic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific cd4+cd25+ regulatory t cells for haematopoietic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857703

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.